• Home>
  • Stocks>
  • Shukra Pharmaceuticals Ltd Share Price
Shukra Pharmaceuticals Ltd share price logo

Shukra Pharmaceuticals Ltd Share Price

BSE: 524632

Small Cap

Healthcare Sector

₹40.27

+0.78

(+1.98%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Shukra Pharmaceuticals Ltd Stock Performance

as on October 24, 2025 at 4:01 pm IST

  • ₹40.27
    ₹40.27

  • 52 Week's Low

    ₹5.75
    ₹40.27
    downward going graph

    85.72%

    Downside

Shukra Pharmaceuticals Ltd share price movements today

Previous Close
₹39.49
Open
₹40.27
Volume
38.56K
Upper Circuit
₹40.27
Lower Circuit
₹38.71
Day's Low - High
₹40.27 - ₹40.27
52 Week Low - High
₹5.75 - ₹40.27

Shukra Pharmaceuticals Ltd Historical Returns

1 Month Return
+ 19.11 %
3 Month Return
+ 106.3 %
1 Year Return
+ 526.28 %
3 Year Return
+ 3663.55 %
5 Year Return
+ 14282.14 %

Shukra Pharmaceuticals Ltd Fundamentals

as on October 24, 2025 at 4:01 pm IST

Market Cap

₹1,763.34 Cr

Return on Equity (ROE)

15.9

PE Ratio (TTM)

0

Return on capital employed (ROCE)

21.76

Beta (LTM)

-0.28

P/B Ratio

15.17

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

110.2

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Shukra Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Shukra Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,763.342856.43%0.00932
Vivanza Biosciences Ltd image
Vivanza Biosciences Ltd
NA8.04-7.32%0.84-17
Granules India Ltd image
Granules India Ltd
BUY13,699.869.62%0.645014,481
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA10.5741.65%0.00NA13
Zenlabs Ethica Ltd image
Zenlabs Ethica Ltd
NA18.461.16%0.00NA51
See all

Shukra Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Shukra Pharmaceuticals Ltd Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1% versus previous 30 day period

Shukra Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
2.3
46.25
20.16
24.64
18.89
10.88
3.18
5.56
10.58
13.27
5.39
Other Income
0.27
0.89
0.63
0.24
0.56
1.38
0.72
1.02
1.01
1.47
1.11
Total Income
2.57
47.14
20.79
24.88
19.45
12.26
3.9
6.57
11.59
14.74
6.5
Expenses
2.02
42.59
19.82
19.55
9.35
6.45
2.37
4.89
6.65
5.95
4.07
Operating Profit
0.28
3.66
0.34
5.09
9.54
4.43
0.81
0.67
3.93
7.32
1.32
Operating Profit Margin %
12.17%
7.91%
1.69%
20.66%
50.5%
40.72%
25.47%
12.05%
37.15%
55.16%
24.49%
Profit Before Interest, Tax and Depreciation
0.55
4.54
0.97
5.33
10.11
5.81
1.52
1.68
4.94
8.78
2.43
Interest
0.05
0.07
0.08
0.06
0.07
0.07
0.06
0.11
0.15
0.27
0.27
Depreciation
0.46
0.51
0.46
0.56
0.51
0.52
0.67
0.7
0.7
0.94
0.79
Profit Before Tax
0.04
3.96
0.43
4.71
9.53
5.22
0.79
0.87
4.09
7.57
1.37
Tax Paid
0.02
-0.01
0.01
-0.01
0.1
1.24
0.32
0.34
0.93
2.18
0.35
Profit After Tax
0.03
3.98
0.42
4.71
9.42
3.99
0.49
0.54
3.16
5.39
1.03
Total Net profit including share of profit / Loss from associate company
0.03
3.98
0.42
4.71
9.42
3.99
0.49
0.54
3.16
5.39
1.03
EPS
0.16
10.14
0.59
1.47
8.61
3.64
0.11
0.12
0.72
0.12
0.02
Actual EPS
0.16
10.14
0.59
1.47
8.61
3.64
0.11
0.12
0.72
0.12
0.02
Adjusted EPS
0
0.25
0.01
0.04
0.21
0.09
0.01
0.01
0.07
0.12
0.02
Diluted EPS
0.16
10.14
0.59
1.47
8.61
3.64
0.11
0.12
0.72
0.12
0.02

Shukra Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
5.14
5.36
5.66
11.85
11.2
20.49
58.83
74.57
32.59
Other Income
0.07
0.11
0.04
0.11
0.36
0.08
1.2
2.82
4.21
Total Income
5.2
5.47
5.7
11.96
11.55
20.57
60.03
77.39
36.79
Expenses
3.67
3.74
4.01
10.31
9.95
17.6
53.47
55.17
19.86
Operating Profit
1.47
1.62
1.65
1.54
1.25
2.89
5.36
19.4
12.73
Operating Profit Margin %
28.6%
30.22%
29.15%
13%
11.16%
14.1%
9.11%
26.02%
39.06%
Profit Before Interest, Tax and Depreciation
1.53
1.73
1.69
1.65
1.6
2.97
6.56
22.22
16.94
Interest
0.01
0.05
-
-
0.03
0.29
0.28
0.29
0.59
Depreciation
0.47
0.74
0.96
1.48
1.47
1.66
1.84
2.05
3
Profit Before Tax
1.05
0.94
0.73
0.17
0.1
1.02
4.44
19.88
13.35
Tax Paid
0.56
-0.08
0.26
0.14
0.07
0.27
0.04
1.34
3.76
Profit After Tax
0.5
1.02
0.46
0.04
0.03
0.75
4.41
18.54
9.58
Total Net profit including share of profit / Loss from associate company
0.5
1.02
0.46
0.04
0.03
0.75
4.41
18.54
9.58
EPS
4.21
6.54
2.95
0.23
0.22
4.79
11.23
16.93
0.22
Actual EPS
4.21
6.54
2.95
0.23
0.22
4.79
11.23
16.93
0.22
Adjusted EPS
0.02
0.03
0.02
0
0
0.02
0.28
0.42
0.22
Diluted EPS
4.21
6.54
2.95
0.23
0.22
4.79
11.23
16.93
0.22

Shukra Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
2.72
-0.29
0.84
0.26
1.24
0.54
7.99
3.17
-5.2
7.92
Cash Flow from Investing Activities
-0.41
-0.93
-4.75
-2.45
-3.35
-1.88
-1.53
-4.43
-1.2
-1.26
Cash Flow from Financing Activities
-1.16
-
3.46
2.38
1.99
1.74
-6.67
4.94
12.4
-4.51
Net Cash Flow
1.15
-1.22
-0.46
0.18
-0.12
0.38
-0.21
3.68
6.01
2.14

Shukra Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
49.17%
50.9%
50.9%
50.9%
50.9%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
DII
0.8%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
Public
50.04%
48.99%
48.99%
48.99%
48.99%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
Total Outstanding Shares
15,65,675
1,09,59,725
1,09,59,725
1,09,59,725
1,09,59,725
1,09,46,986
1,09,46,986
4,37,87,944
4,37,87,944
4,37,87,944
43,78,79,440
43,78,79,440
Total Shareholders
9,234
9,531
9,582
9,600
9,747
10,963
12,974
14,989
16,321
17,844
18,231
20,337

Shukra Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Shukra Pharmaceuticals Ltd.

  • Shukra Pharmaceuticals Ltd Earnings Results

    Shukra Pharmaceuticals Ltd’s net profit jumped 110.2% since last year same period to ₹1.03Cr in the Q1 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated -80.89% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Shukra Pharmaceuticals Ltd Dividends June,2025

    In the quarter ending March 2025, Shukra Pharmaceuticals Ltd has declared dividend of ₹0.01 per share on 04 Jun 2025 - translating a dividend yield of 0.02%.

    Read More about Dividends

Insights on Shukra Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, Shukra Pharma. stock has moved up by 3663.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.96% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 48.93% of holdings in Jun 2025 quarter

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd Formerly known Relish Pharmaceuticals Limited was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics Penicillin Anti Biotics Cephalosporin Anti Biotics Macrolides Quinolones Anti Bacterial Anti Fungal Anti Malarial Anti Viral Anti Protozoal Anti Anthelmintic Sedative and Tranquilliser Anti Depressant Anti Manic Anti Emetic Anti Ulcer Beta Blockers Diuretics Analgesic Analgesic NASID Muscle Relaxants Anti Tuberculosis Vitamin Products Anti Allergics Corticosteroids Hyper and Hypoglycemic Others.The company has four manufacturing divisions namely tablets General and Beta Lactum Capsules General and Beta Lactum Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited Zydus Intas Pharmaceuticals Limited Cadila Pharmaceuticals Limited Makers Laboratories Limited Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314 the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited Transferor Company with Relish Pharmaceuticals Limited Transferee Company and Reorganization of Share Capital of Relish Pharmaceuticals Limited Transferee Company through Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 Dec 2013..

Revenue: ₹5.39Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1.03Cr as on June 2025 (Q1 FY26)
Chairperson Name: Dakshesh Shah
OrganisationShukra Pharmaceuticals Ltd
IndustryPharmaceuticals
CEODakshesh Shah
E-voting on sharesClick here to vote

FAQs

What is Shukra Pharmaceuticals Ltd share price today?

Shukra Pharmaceuticals Ltd share price today stands at ₹40.27 as on at the close of the market. Shukra Pharmaceuticals Ltd share today touched a day high of ₹40.27 and a low of ₹40.27.

What is the 52 week high and 52 week low range for Shukra Pharmaceuticals Ltd share?

Shukra Pharmaceuticals Ltd touched a 52 week high of ₹40.27 and a 52 week low of ₹5.75. Shukra Pharmaceuticals Ltd share price today i.e. is closed at ₹40.27, which is -0.00% down from its 52 week high and 600.35% up from its 52 week low.

What is Shukra Pharmaceuticals Ltd's market capitalisation today?

Shukra Pharmaceuticals Ltd market capitalisation is ₹1,763.34 Cr as on .

How to buy Shukra Pharmaceuticals Ltd shares?

To buy Shukra Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524632 or Shukra Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Shukra Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Shukra Pharmaceuticals Ltd trading volume today?

Shukra Pharmaceuticals Ltd trading volume is 38.56K as on . This means that 38.56K shares of Shukra Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.